Quantcast

Latest Bevacizumab Stories

2012-06-13 10:14:54

USC Norris Comprehensive Cancer Center physician-researchers collaborated on more than 70 research projects presented at the 2012 annual meeting of the American Society of Clinical Oncology (ASCO) this month. Roughly 30,000 cancer specialists from around the world attend the annual meeting to discuss the latest techniques, drugs and research in cancer care. ASCO, founded in 1964, is an offshoot of the American Association of Cancer Research dedicated to clinical oncology. Studies...

2012-06-11 21:33:18

Study finds that the behavior of molecular imaging probes can indicate the effectiveness of a targeted therapy for patients with locally advanced rectal cancer A study presented at the Society of Nuclear Medicine's 2012 Annual Meeting reveals how molecular imaging biomarkers can be used to approximate howan experimental radiochemotherapy for locally advanced rectal cancer will work. Using already available imaging probes, scientists can assess the effectiveness before the course of...

2012-05-22 00:03:26

VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery could be an important step towards personalized medicine and patient-tailored use of this important cancer drug. Diether Lambrechts (VIB — KU Leuven) said "in two large clinical studies with patients with advanced stages of pancreas and kidney cancer a variant in...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.